Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

JEMPERLI 500 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
dostarlimab
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
L01FF07
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Jemperli (dostarlimab) Patient card

{healthcare_pro_orange} For Healthcare Professionals
Jemperli (dostarlimab) Patient card

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]